A meta-analysis of more than 228 publications revealed that high OPN levels in plasma or tissue were correlated with decreased overall survival (OS) and disease-free survival (DFS) in different tumor types, including lung cancer, breast cancer, head and neck cancer, liver cancer, and prostate cancer [33]. This evidence concerns the gene SPP1 and lung carcinoma.